nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—DRD4—Gilles de la Tourette syndrome	0.27	0.343	CbGaD
Ziprasidone—DRD3—Gilles de la Tourette syndrome	0.233	0.295	CbGaD
Ziprasidone—DRD2—Gilles de la Tourette syndrome	0.161	0.204	CbGaD
Ziprasidone—HTR2A—Gilles de la Tourette syndrome	0.124	0.158	CbGaD
Ziprasidone—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00357	0.0587	CbGeAlD
Ziprasidone—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00223	0.0366	CbGeAlD
Ziprasidone—Lurasidone—DRD2—Gilles de la Tourette syndrome	0.00184	0.267	CrCbGaD
Ziprasidone—Lurasidone—HTR2A—Gilles de la Tourette syndrome	0.00142	0.206	CrCbGaD
Ziprasidone—HTR1E—nervous system—Gilles de la Tourette syndrome	0.00124	0.0204	CbGeAlD
Ziprasidone—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00119	0.0196	CbGeAlD
Ziprasidone—DRD4—brain—Gilles de la Tourette syndrome	0.0011	0.018	CbGeAlD
Ziprasidone—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00109	0.0178	CbGeAlD
Ziprasidone—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.00105	0.0172	CbGeAlD
Ziprasidone—DRD3—nervous system—Gilles de la Tourette syndrome	0.00101	0.0166	CbGeAlD
Ziprasidone—DRD3—central nervous system—Gilles de la Tourette syndrome	0.000972	0.016	CbGeAlD
Ziprasidone—HTR6—nervous system—Gilles de la Tourette syndrome	0.000972	0.016	CbGeAlD
Ziprasidone—HTR1E—brain—Gilles de la Tourette syndrome	0.000947	0.0156	CbGeAlD
Ziprasidone—DRD5—nervous system—Gilles de la Tourette syndrome	0.000946	0.0156	CbGeAlD
Ziprasidone—HTR6—central nervous system—Gilles de la Tourette syndrome	0.000936	0.0154	CbGeAlD
Ziprasidone—DRD5—central nervous system—Gilles de la Tourette syndrome	0.000911	0.015	CbGeAlD
Ziprasidone—H1F0—midbrain—Gilles de la Tourette syndrome	0.00089	0.0146	CbGeAlD
Ziprasidone—DRD1—midbrain—Gilles de la Tourette syndrome	0.000879	0.0145	CbGeAlD
Ziprasidone—CHRM5—nervous system—Gilles de la Tourette syndrome	0.000849	0.014	CbGeAlD
Ziprasidone—CHRM4—brain—Gilles de la Tourette syndrome	0.00083	0.0136	CbGeAlD
Ziprasidone—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.000817	0.0134	CbGeAlD
Ziprasidone—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.000776	0.0127	CbGeAlD
Ziprasidone—DRD3—brain—Gilles de la Tourette syndrome	0.000772	0.0127	CbGeAlD
Ziprasidone—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000747	0.0123	CbGeAlD
Ziprasidone—HTR6—brain—Gilles de la Tourette syndrome	0.000743	0.0122	CbGeAlD
Ziprasidone—Aripiprazole—DRD4—Gilles de la Tourette syndrome	0.000734	0.107	CrCbGaD
Ziprasidone—H1F0—nervous system—Gilles de la Tourette syndrome	0.000732	0.012	CbGeAlD
Ziprasidone—DRD5—brain—Gilles de la Tourette syndrome	0.000723	0.0119	CbGeAlD
Ziprasidone—DRD1—nervous system—Gilles de la Tourette syndrome	0.000723	0.0119	CbGeAlD
Ziprasidone—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000712	0.0117	CbGeAlD
Ziprasidone—H1F0—central nervous system—Gilles de la Tourette syndrome	0.000705	0.0116	CbGeAlD
Ziprasidone—HTR3A—nervous system—Gilles de la Tourette syndrome	0.000698	0.0115	CbGeAlD
Ziprasidone—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000696	0.0114	CbGeAlD
Ziprasidone—HTR1D—midbrain—Gilles de la Tourette syndrome	0.00069	0.0113	CbGeAlD
Ziprasidone—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000683	0.0112	CbGeAlD
Ziprasidone—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.000672	0.011	CbGeAlD
Ziprasidone—CHRM5—brain—Gilles de la Tourette syndrome	0.000649	0.0107	CbGeAlD
Ziprasidone—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.000648	0.0106	CbGeAlD
Ziprasidone—Aripiprazole—DRD3—Gilles de la Tourette syndrome	0.000633	0.0919	CrCbGaD
Ziprasidone—ADRA1B—brain—Gilles de la Tourette syndrome	0.000593	0.00974	CbGeAlD
Ziprasidone—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000586	0.00963	CbGeAlD
Ziprasidone—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000583	0.00958	CbGeAlD
Ziprasidone—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000575	0.00945	CbGeAlD
Ziprasidone—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000567	0.00932	CbGeAlD
Ziprasidone—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000564	0.00927	CbGeAlD
Ziprasidone—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000562	0.00923	CbGeAlD
Ziprasidone—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000561	0.00922	CbGeAlD
Ziprasidone—H1F0—brain—Gilles de la Tourette syndrome	0.00056	0.0092	CbGeAlD
Ziprasidone—DRD1—brain—Gilles de la Tourette syndrome	0.000553	0.00908	CbGeAlD
Ziprasidone—HTR7—midbrain—Gilles de la Tourette syndrome	0.000549	0.00903	CbGeAlD
Ziprasidone—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000546	0.00897	CbGeAlD
Ziprasidone—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000541	0.00889	CbGeAlD
Ziprasidone—HTR3A—brain—Gilles de la Tourette syndrome	0.000534	0.00877	CbGeAlD
Ziprasidone—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000532	0.00875	CbGeAlD
Ziprasidone—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00053	0.00872	CbGeAlD
Ziprasidone—DRD2—midbrain—Gilles de la Tourette syndrome	0.00052	0.00854	CbGeAlD
Ziprasidone—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000513	0.00842	CbGeAlD
Ziprasidone—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000512	0.00841	CbGeAlD
Ziprasidone—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000511	0.00839	CbGeAlD
Ziprasidone—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000505	0.0083	CbGeAlD
Ziprasidone—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000475	0.0078	CbGeAlD
Ziprasidone—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000473	0.00777	CbGeAlD
Ziprasidone—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000457	0.00751	CbGeAlD
Ziprasidone—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000455	0.00748	CbGeAlD
Ziprasidone—HTR7—nervous system—Gilles de la Tourette syndrome	0.000452	0.00742	CbGeAlD
Ziprasidone—HTR1B—brain—Gilles de la Tourette syndrome	0.000448	0.00736	CbGeAlD
Ziprasidone—CHRM2—brain—Gilles de la Tourette syndrome	0.000445	0.00732	CbGeAlD
Ziprasidone—Aripiprazole—DRD2—Gilles de la Tourette syndrome	0.000438	0.0636	CrCbGaD
Ziprasidone—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000436	0.00716	CbGeAlD
Ziprasidone—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000435	0.00715	CbGeAlD
Ziprasidone—HTR1D—brain—Gilles de la Tourette syndrome	0.000433	0.00712	CbGeAlD
Ziprasidone—HTR2C—brain—Gilles de la Tourette syndrome	0.000429	0.00706	CbGeAlD
Ziprasidone—DRD2—nervous system—Gilles de la Tourette syndrome	0.000427	0.00702	CbGeAlD
Ziprasidone—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000421	0.00692	CbGeAlD
Ziprasidone—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000419	0.0069	CbGeAlD
Ziprasidone—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000415	0.00682	CbGeAlD
Ziprasidone—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000411	0.00676	CbGeAlD
Ziprasidone—SLC6A4—brain—Gilles de la Tourette syndrome	0.000407	0.00669	CbGeAlD
Ziprasidone—CHRM1—brain—Gilles de la Tourette syndrome	0.000405	0.00666	CbGeAlD
Ziprasidone—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.000405	0.00666	CbGeAlD
Ziprasidone—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000403	0.00662	CbGeAlD
Ziprasidone—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.0004	0.00657	CbGeAlD
Ziprasidone—Clozapine—DRD4—Gilles de la Tourette syndrome	0.000395	0.0573	CrCbGaD
Ziprasidone—CHRM3—brain—Gilles de la Tourette syndrome	0.000363	0.00596	CbGeAlD
Ziprasidone—HTR1A—brain—Gilles de la Tourette syndrome	0.000361	0.00594	CbGeAlD
Ziprasidone—HTR7—brain—Gilles de la Tourette syndrome	0.000345	0.00568	CbGeAlD
Ziprasidone—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000343	0.00563	CbGeAlD
Ziprasidone—Clozapine—DRD3—Gilles de la Tourette syndrome	0.00034	0.0494	CrCbGaD
Ziprasidone—Aripiprazole—HTR2A—Gilles de la Tourette syndrome	0.000338	0.0491	CrCbGaD
Ziprasidone—HRH1—nervous system—Gilles de la Tourette syndrome	0.000337	0.00554	CbGeAlD
Ziprasidone—Trazodone—HTR2A—Gilles de la Tourette syndrome	0.000337	0.0489	CrCbGaD
Ziprasidone—ADRA1A—brain—Gilles de la Tourette syndrome	0.000333	0.00547	CbGeAlD
Ziprasidone—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000331	0.00545	CbGeAlD
Ziprasidone—DRD2—brain—Gilles de la Tourette syndrome	0.000326	0.00537	CbGeAlD
Ziprasidone—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000325	0.00534	CbGeAlD
Ziprasidone—KCNH2—brain—Gilles de la Tourette syndrome	0.000322	0.00529	CbGeAlD
Ziprasidone—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000319	0.00524	CbGeAlD
Ziprasidone—ADRA2C—brain—Gilles de la Tourette syndrome	0.000317	0.00522	CbGeAlD
Ziprasidone—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000282	0.00463	CbGeAlD
Ziprasidone—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000271	0.00446	CbGeAlD
Ziprasidone—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000261	0.00429	CbGeAlD
Ziprasidone—HRH1—brain—Gilles de la Tourette syndrome	0.000258	0.00424	CbGeAlD
Ziprasidone—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000257	0.00422	CbGeAlD
Ziprasidone—ADRA2A—brain—Gilles de la Tourette syndrome	0.000253	0.00416	CbGeAlD
Ziprasidone—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000251	0.00413	CbGeAlD
Ziprasidone—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000247	0.00406	CbGeAlD
Ziprasidone—Clozapine—DRD2—Gilles de la Tourette syndrome	0.000236	0.0342	CrCbGaD
Ziprasidone—HTR2A—brain—Gilles de la Tourette syndrome	0.000215	0.00354	CbGeAlD
Ziprasidone—CYP2D6—brain—Gilles de la Tourette syndrome	0.000196	0.00322	CbGeAlD
Ziprasidone—Clozapine—HTR2A—Gilles de la Tourette syndrome	0.000182	0.0264	CrCbGaD
Ziprasidone—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.15e-05	0.000218	CbGpPWpGaD
Ziprasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.15e-05	0.000218	CbGpPWpGaD
Ziprasidone—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.13e-05	0.000217	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.09e-05	0.000215	CbGpPWpGaD
Ziprasidone—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.07e-05	0.000213	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.05e-05	0.000212	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.05e-05	0.000211	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.03e-05	0.00021	CbGpPWpGaD
Ziprasidone—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.03e-05	0.00021	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.02e-05	0.000209	CbGpPWpGaD
Ziprasidone—DRD5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.01e-05	0.000209	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.01e-05	0.000209	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.01e-05	0.000209	CbGpPWpGaD
Ziprasidone—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3e-05	0.000208	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.99e-05	0.000208	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.95e-05	0.000205	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.93e-05	0.000203	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.93e-05	0.000203	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.9e-05	0.000201	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.88e-05	0.0002	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.88e-05	0.0002	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.87e-05	0.000199	CbGpPWpGaD
Ziprasidone—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.86e-05	0.000198	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.85e-05	0.000197	CbGpPWpGaD
Ziprasidone—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.82e-05	0.000196	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.82e-05	0.000195	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.8e-05	0.000194	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.79e-05	0.000193	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.75e-05	0.000191	CbGpPWpGaD
Ziprasidone—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.74e-05	0.00019	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.73e-05	0.00019	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.72e-05	0.000189	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.72e-05	0.000189	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.7e-05	0.000188	CbGpPWpGaD
Ziprasidone—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.68e-05	0.000186	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.64e-05	0.000183	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.63e-05	0.000183	CbGpPWpGaD
Ziprasidone—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.63e-05	0.000182	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.63e-05	0.000182	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.62e-05	0.000182	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.61e-05	0.000181	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.61e-05	0.000181	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.6e-05	0.00018	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.59e-05	0.00018	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.000179	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.000179	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.56e-05	0.000178	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.56e-05	0.000177	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.55e-05	0.000177	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.55e-05	0.000177	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.55e-05	0.000177	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.51e-05	0.000174	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.48e-05	0.000172	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.48e-05	0.000172	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.47e-05	0.000171	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.46e-05	0.000171	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.46e-05	0.00017	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.45e-05	0.00017	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.4e-05	0.000166	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.4e-05	0.000166	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.39e-05	0.000166	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.39e-05	0.000166	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000165	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.38e-05	0.000165	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	2.36e-05	0.000164	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.35e-05	0.000163	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.35e-05	0.000163	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.34e-05	0.000163	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.34e-05	0.000163	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.34e-05	0.000162	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.33e-05	0.000162	CbGpPWpGaD
Ziprasidone—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000161	CbGpPWpGaD
Ziprasidone—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.32e-05	0.000161	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.32e-05	0.000161	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.32e-05	0.000161	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.31e-05	0.000161	CbGpPWpGaD
Ziprasidone—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.31e-05	0.00016	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.31e-05	0.00016	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.31e-05	0.00016	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.3e-05	0.00016	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.28e-05	0.000158	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.28e-05	0.000158	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.28e-05	0.000158	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.27e-05	0.000157	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.26e-05	0.000157	CbGpPWpGaD
Ziprasidone—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.26e-05	0.000157	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.24e-05	0.000155	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.23e-05	0.000155	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.23e-05	0.000155	CbGpPWpGaD
Ziprasidone—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.22e-05	0.000154	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.000154	CbGpPWpGaD
Ziprasidone—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.19e-05	0.000152	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.17e-05	0.00015	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.16e-05	0.00015	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.14e-05	0.000148	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.13e-05	0.000148	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.13e-05	0.000148	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.13e-05	0.000148	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.12e-05	0.000147	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.12e-05	0.000147	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.12e-05	0.000147	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.11e-05	0.000147	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.11e-05	0.000147	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.11e-05	0.000147	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.11e-05	0.000146	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.11e-05	0.000146	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.1e-05	0.000146	CbGpPWpGaD
Ziprasidone—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.1e-05	0.000146	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.1e-05	0.000145	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.09e-05	0.000145	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.09e-05	0.000145	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.09e-05	0.000145	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.08e-05	0.000144	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.07e-05	0.000144	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.07e-05	0.000144	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.07e-05	0.000143	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.06e-05	0.000143	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.05e-05	0.000142	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.05e-05	0.000142	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.03e-05	0.000141	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.03e-05	0.000141	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.00014	CbGpPWpGaD
Ziprasidone—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2e-05	0.000139	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	2e-05	0.000139	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.99e-05	0.000138	CbGpPWpGaD
Ziprasidone—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.98e-05	0.000137	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.97e-05	0.000137	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.97e-05	0.000137	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.96e-05	0.000136	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.94e-05	0.000135	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.93e-05	0.000134	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.93e-05	0.000134	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.92e-05	0.000134	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.92e-05	0.000133	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.91e-05	0.000133	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.91e-05	0.000133	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.91e-05	0.000133	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.91e-05	0.000133	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.91e-05	0.000132	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.9e-05	0.000132	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.89e-05	0.000131	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.89e-05	0.000131	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.88e-05	0.000131	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.88e-05	0.000131	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.86e-05	0.000129	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.86e-05	0.000129	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000127	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.82e-05	0.000126	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.8e-05	0.000125	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.79e-05	0.000125	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.78e-05	0.000124	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.78e-05	0.000124	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.78e-05	0.000124	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.78e-05	0.000124	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.77e-05	0.000123	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.75e-05	0.000122	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.73e-05	0.00012	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.73e-05	0.00012	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.00012	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.71e-05	0.000119	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.7e-05	0.000118	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.7e-05	0.000118	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.68e-05	0.000117	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.67e-05	0.000116	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.65e-05	0.000114	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.64e-05	0.000114	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.62e-05	0.000113	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.62e-05	0.000112	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.62e-05	0.000112	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.61e-05	0.000112	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.56e-05	0.000109	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.56e-05	0.000108	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	1.54e-05	0.000107	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.53e-05	0.000106	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.51e-05	0.000105	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.51e-05	0.000105	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.51e-05	0.000105	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.51e-05	0.000105	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.000103	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.48e-05	0.000103	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.48e-05	0.000103	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.48e-05	0.000102	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.47e-05	0.000102	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.46e-05	0.000101	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.46e-05	0.000101	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.46e-05	0.000101	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.45e-05	0.000101	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.42e-05	9.83e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.41e-05	9.79e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.41e-05	9.78e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.39e-05	9.64e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.37e-05	9.53e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.37e-05	9.51e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.37e-05	9.48e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.35e-05	9.39e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.35e-05	9.36e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.35e-05	9.36e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.34e-05	9.33e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.34e-05	9.3e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.33e-05	9.21e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.32e-05	9.18e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.32e-05	9.15e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.31e-05	9.11e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.28e-05	8.89e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.28e-05	8.86e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.26e-05	8.74e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.26e-05	8.73e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.26e-05	8.72e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.25e-05	8.7e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.25e-05	8.67e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.25e-05	8.66e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.25e-05	8.65e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.24e-05	8.63e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.24e-05	8.6e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.24e-05	8.59e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.23e-05	8.56e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.23e-05	8.53e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.22e-05	8.49e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.22e-05	8.47e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.22e-05	8.44e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.21e-05	8.42e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.21e-05	8.42e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.2e-05	8.33e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.2e-05	8.31e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.19e-05	8.28e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.18e-05	8.17e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.15e-05	7.96e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.14e-05	7.91e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.14e-05	7.89e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.13e-05	7.87e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.13e-05	7.84e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.13e-05	7.82e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.12e-05	7.76e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.12e-05	7.74e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.11e-05	7.72e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.07e-05	7.46e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.06e-05	7.36e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.04e-05	7.19e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.57e-06	6.64e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.24e-06	6.41e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.19e-06	6.38e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.94e-06	6.2e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.8e-06	6.11e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.11e-06	5.63e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.96e-06	5.53e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.94e-06	5.51e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.91e-06	5.49e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.84e-06	5.44e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.81e-06	5.42e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.26e-06	5.04e-05	CbGpPWpGaD
